Sponsor:
New Phase Ltd.
Code:
NCT07224464
Conditions
Metastatic Solid Tumors
Stage 4 Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
The Sarah Nanotechnology System - intended to deliver thermal energy to malignant cells for the purpose of thermal destruction of these cells in patients with advanced metastatic solid tumors.
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-27. This information was provided to ClinicalTrials.gov by New Phase Ltd. on 2025-12-02.